Study: No association between montelukast and neuropsychiatric adverse event risk
"In aggregation with other robust observational studies, these results can inform the management of asthma and allergic rhinitis in this patient group," wrote the study authors.
Pediatric obesity treatment yields lower morbidity, mortality risk in young adults
"The greatest risk reductions were demonstrated in those who experienced obesity remission during childhood," stated study authors.
Discussing pediatric vaccination with vaccine-hesitant parents
Robert Frenck, MD, offers several practical tips to use when discussing pediatric vaccination among vaccine-hesitant parents.
Pediatric pulmonary arterial hypertension and the pediatrician
Principal investigator Lewis Romer, MD, of Johns Hopkins Medicine joined us to discuss the actively-recruiting MoD PAH trial, and explains the role the pediatrician can play in care and recruitment.
Weekly review: New neffy PDUFA, crinecerfont discussion for CAH, and more
Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.
Calling out signs of addictive behavior around social media or binge eating
Susan Carnell, PhD, highlights the nuanced relationship between social media use and binge eating in adolescents, noting the importance of addressing addictive behaviors and seeking support when needed.
HHS expands Medicare drug price negotiations to add 15 medications
HHS selects 15 more Medicare Part D drugs for price negotiation under the Inflation Reduction Act, aiming to lower costs for millions by 2027.
Quick reactions to the FDA ban of FD&C red No. 3
Read these quick comments from Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, and Bernard Cohen, MD, regarding the banning of red No. 3 from foods and ingested drugs.
FDA expands immobilized lipase cartridge clearance down to 1 year
The digestive enzyme cartridge is designed to mimic pancreatic lipase function.
CDC: Most US teens fail to get recommended 8 hours of sleep, report finds
A CDC report shows only 23% of U.S. teens get enough sleep, with disparities highlighting the need for targeted health interventions.
CDC: 2013-2023 youth risk physical activity behavior report
Across all years in the report, the CDC rated each physical activity trend with a color of red, indicating that trends are going in the "wrong direction."
Kyriakie Sarafoglou, MD, discusses crinecerfont FDA approval for congenital adrenal hyperplasia
The lead clinical trial investigator for a phase 3 study of crinecerfont in pediatric CAH patients breaks down the December 2024 FDA approval.
Despite decreases of invalid vaccine doses, series completion still lacks
Of those with a minimum age or minimum interval vaccine dose, 44.9% ended up receiving extra doses to complete a vaccination series.
Investigating mono vs dual therapy for pediatric pulmonary arterial hypertension
Principal investigator Lewis Romer, MD, of Johns Hopkins Medicine joined us to discuss the actively-recruiting MoD PAH trial assessing mono vs dual therapy for pediatric PAH.
PDUFA date set for neffy 1 mg for children who weigh 33 lbs or more
Neffy was first approved in September 2024 to treat type 1 allergic reactions in patients who weigh at least 66 lbs (33 kg).
Weekly review: New peanut patch data, norovirus outbreaks, and more
Addictive behaviors surrounding social media could lead to binge eating
Results from a recent study revealed that compulsive and addictive elements can contribute to the risk of disordered eating. Study investigator Susan Carnell, PhD, explains these findings.
Data: 80% of INZ-701-treated infants with ENPP1 Deficiency survived past first year
Positive interim data was reported from the ENERGY 1 trial and Expanded Access Program that featured a total of 5 infants and 1 child.
New data: Viaskin Peanut patch improves treatment benefit through 36 months
In an open-label extension of the EPITOPE phase 3 trial, the Viaskin Peanut patch had continued improvement in toddlers aged 1-3 years through 36 months.
CDC: 2024-2025 seasonal norovirus outbreaks up from previous years
Based on reports by NoroSTAT-participating states, the total number of outbreaks in 2024-2025 seasonal year is above the range reported 012–2020 and 2021-2024 seasonal years.
Study: Nearly 80% of infants born in 2023-24 RSV season received RSV protection
The study within a single health care system revealed that most infants born prior to December received the nirsevimab monoclonal antibody.
Maternal medications linked to reduced protein and fat in breast milk
A recent study highlights potential reductions in macronutrient levels in breast milk because of maternal medications, though breastfeeding remains strongly recommended.
Screen time under 2 years of age and autism risk at 12 years
Recent research evaluated the association between screen time and autism spectrum disorder by considering socioeconomic factors as instrumental variables.
New research details rarity of gender-affirming medications prescribed to US adolescents
In this cross-sectional population of insured adolescents from 2018 to 2022, receipt of puberty blockers and hormones was rare.
Robert Frenk, MD: 2024 was big year for RSV prevention
Robert Frenck, MD, explained why 2024 was a big step in the right direction for RSV prevention, and emphasized the importance of vaccination against preventable diseases.
Social media use and binge eating in early adolescence
Susan Carnell, PhD explains social media addiction symptoms, but not time on social media, were cross-sectionally and prospectively associated with binge eating.
Case study: Boy, aged 10 years, has painful nodules on his feet
Medical advice was sought on the fifth day of symptoms, and by this time, the child was improving clinically.
Can you diagnose this boy with painful nodules on his feet?
The photos in this case were taken soon after the painful and red papules appeared.
Parent text reminders improve child oral health behaviors
Among a low-income and racially/ethnically diverse sample of caregiver child dyads, text intervention was effective for toothbrushing, preventive dentist visits, and more.
Prenatal systemic glucocorticoids exposure linked to higher risk of some mental disorders
Findings support continued caution in the use of glucocorticoids among pregnant people.
